📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. (2023)

First Author: Swen JJ
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01841-4

PubMed Identifier: 36739136

Publication URI: http://europepmc.org/abstract/MED/36739136

Type: Journal Article/Review

Volume: 401

Parent Publication: Lancet (London, England)

Issue: 10374

ISSN: 0140-6736